How to treat recurrence of rectal cancer after surgery

What should I do if rectal cancer recurs after surgery? If you are in good health after rectal cancer metastasis, you can consider a second surgery. If you are intolerant to surgery, you can undergo chemotherapy. Let's take a look at the specific methods. I hope it will be helpful to everyone.

International clinical research data show that patients with rectal cancer metastasis who receive the molecular targeted drug Erbitux have more stable conditions than those who receive traditional chemotherapy, further proving the effectiveness of Erbitux in both first-line and follow-up treatment of rectal cancer metastasis. The efficacy is even more significant for patients with rectal cancer with liver metastasis.
These results are of great significance because they show that for patients with rectal cancer metastasis who are not originally able to undergo complete resection surgery, the combination of Erbitux and other drugs can significantly increase the tumor response rate and resection rate, thereby significantly increasing the chances of cure for patients with rectal cancer metastasis.
A new treatment for rectal cancer metastasis, Erbitux, is an IgG1 monoclonal antibody that can specifically bind to the epidermal growth factor receptor EGFR, thereby blocking the EGFR signaling pathway and affecting all functions of tumor cell growth and metastasis, such as cell proliferation, survival, DNA replication, tumor angiogenesis, cell migration and invasion.